IP Library Granted Patent US 7,709,022
Granted Patent B2
US 7,709,022 · App. 10/311,913 · Granted May 4, 2010

Sustained-release preparations of quinolone antibiotics and method for preparation thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,709,022
App. No.
10/311,913
Granted
May 4, 2010
Kind
B2
Abstract

The present invention relates to an orally administrable preparation comprising a quinolone antibiotic which releases the active compound with a delay.

Claims (13)

1. Orally administrable preparation comprising ciprofloxacin as an active compound, characterized in that it contains a mixture of

a) gel-forming polymer which is a cellulose ether of a viscosity of 5 to 400 cP, measured as 2% polymer concentration by weight aqueous solution at 20° C., and

b) a mixture of a salt with the free base of ciprofloxacin at a salt-to-free base weight ratio of from about 1.3:1 to about 1.8:1;

wherein the preparation releases 80% of the active compound both in 0.1 N hydrochloric acid and in acetate buffer at pH 4.5 in the USP XXIV paddle test at 50 revolutions per minute / 37° C. in the course of 1 to 4 hours.

2. The preparation according to claim 1 , characterized in that the salt and the free base are ciprofloxacin hydrochloride and ciprofloxacin betaine, respectively.

3. The preparation according to claim 1 , characterized in that the gel-forming polymer is hydroxypropylmethylcellulose of a viscosity of at most 75 cP, measured as a 2% polymer concentration by weight aqueous solution at 20° C.

4. The preparation according to claim 3 , characterized in that the hydroxypropylmethylcellulose has a viscosity of at most 50 cP, measured as a 2% polymer concentration by weight aqueous solution at 20° C.

5. The preparation according to claim 3 , characterized in that it contains 2 to 20 parts by weight of active compound mixture per part by weight of hydroxypropylmethylcellulose.

6. The preparation according to claim 1 , wherein the gel-forming polymer is selected from the group consisting of alkylcellulose, hydroxyalkylcellulose, carboxyalkylcellulose, alkali metal salts of carboxyalkylcellulose, and crossliniked carboxymethylcellulose.

7. The preparation according to claim 6 , wherein the gel-forming polymer is a hydroxyalkylcellulose.

8. The preparation according to claim 1 , further comprising an organic acid having from 2 to 10 carbon atoms and from 1 to 4 carboxyl groups.

9. The preparation according to claim 8 wherein the organic acid is succinic acid.

10. The preparation according to claim 1 , characterized in that the preparation is a combination preparation comprising a rapid-release (IR) part and a delayed release (CR) part.

Assignments (2)
CHANGE OF NAME Recorded Oct 18, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AG
Reel/Frame 029150/0303 →
MERGER Recorded Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →